East Coast Cannabis News and Culture
Found this video while browsing through the lovely website, UK-based Dope-Smoker. (Take note of their clean, contemporary design. There are so many collegiate-looking weed sites out there bogged down with too much green and pot leaves – nice to see something more modern.)
On a lighter note, my picks for the very few holiday tunes that don’t want me want to impale myself with skewers:
President Reagan meets Jonathan Magbie. At 27 years old, Jonathan would die on the floor of a Washington DC city jail. In 2004 he was arrested for smoking a marijuana blunt to ease the pain he endured as a quadriplegic. photo
6/17/2011 by Chris Goldstein – When President Nixon signed an Executive Order on June 17, 1971 it sent the United States down a costly path of prohibition. This misguided effort pits Americans against each other in a never-ending battle of biology, psychology and human nature. The result has been a nuclear reactor of violence and deadly addiction.
The “War on Drugs” is not a slogan. Ask any Police Officer. Ask anyone who lives in Trenton, Philadelphia or Camden. This is a pitched battle right in our streets and in our homes. Thousands have lost their lives. Millions have gone to prison. Trillions of tax dollars have been spent at every level. There has never been a measurable result, only more victims.
I have seen many levels of this war in person. In high school my Quaker group helped tutor middle-school students in Camden. Spending time in the neighborhoods over the years brought the open air drug trade into quick focus. Then in the late 1990′s I was employed on a contract to test various housing projects in Philadelphia for lead paint. Armed with a computer pack and an x-ray gun we walked through thousands of occupied units in high rises and row homes. This is the no man’s land, communities that have been obliterated by the constant shelling.
For the last decade I have been working on marijuana law reform because it is the key to solving the drug war problem. Cannabis chalks up more arrests every year in the US than for all other drugs combined. The irony is that it was not supposed to be included under criminal prohibitions at all.
When President Nixon made that devastating order in 1971 marijuana was classified with drugs like cocaine as a temporary measure. Nixon tapped a fellow Republican who had just stepped down as Pennsylvania governor to find out how cannabis should be treated. Raymond P. Shafer led The National Commission on Marihuana and Drug Abuse.
This team of sociologists, psychologists, physicians, lawmakers and policy experts toured the country to conduct careful research and observations. Shafer then led the effort to craft the strikingly candid final report: “Marihuana: A Signal of Misunderstanding.” The conclusion was that cannabis should not remain in the narcotic drugs scheme. The Commission went further, recommending that personal possession of cannabis – even transfer for no remuneration – should be decriminalized.
If President Nixon had followed that careful advice we would have never fought a war against marijuana. Instead we would have eventually regulated the cannabis markets for recreation and medication. Hemp farming would be a valuable part of our agricultural economy and sustainable products. But Nixon was not pleased with the Commissions’ assessments and chose to leave them out of policy.
The “War on Drugs” is not a slogan. It is fought with laws, bullets, money, prison cells and human beings. It is fought in front of us every day. And it can stop. A real truce is to begin treating serious drug addiction as a public health problem. In order to pay for that treatment and research we need to legalize marijuana.
But this also brings up the bigger picture: Ending marijuana prohibition and signing a final armistice for the drug war could swiftly jumpstart the national economy – at a time when we need it the most. The tremendous influx of tax revenue from cannabis is already being realized in some places through medical marijuana. This is where the missing jobs could be found, in the millions.
Ending the drug war is the most important social justice and economic policy change we need to make today. After 40 years of failure it is time to try something new.
Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions? [email protected]
Just because you’re buzzed doesn’t mean life stops being annoying. In a perfect world, we’d beam ourselves to a hassle-free planet and ride unicorns and eat marshmallow pies all day.
Until then, we must deal with these 10 buzz kills:
1. Cops
The uniform, the car, the militaristic attitude…goodbye buzz, hello “Can you step out of the vehicle?” (If you’re lucky, it’s a stripper cop and it’s all a great big joke with a sexy ending.)
2. Losing Stuff
My friend Lisa had a rule of thumb: get everything ready before you get stoned. Everything. If you wait until after, you will search endlessly for your keys, phone or general purpose in life. And never find it…never find it.
3. Frigid Temperatures
When I was a flannel-wearing teen lass, I used to hang out at an arcade in South Jersey. Our long-haired gang would pop into the woods on an icy winter’s night to light up. We’d all wonder why we didn’t feel high…until we went back into the arcade and our high would thaw out, just like magic! Head magic.
4. The Rambler
Nothing can be more deadly to a perfectly good high than the Rambler, who starts a story with no intentions of ending it. And because you’re high, you can’t muster up the energy to interject. So instead, you get sucked in, deeper and deeper. Soon your buzz has been bored right the hell out of you, never to return. (The Lecturer has a similar effect.)
5. Your Mother
Okay, some of you get high with your mom and she’s so cool and blah, blah, blah. But parents are similar to cops; you feel like you’ve done something wrong by merely being in their presence. They’re judging, watching all the time. And don’t you forget it.
6. A Blow to the Head
Once during a party I got hit on the head by a lamp while pulling my coat out of the closet. Boom – high completely gone. Fucking lamp.
7. Monsters
They’re fun in the movies but when they are in your living room, they are unpredictable, angry and messy (because of the green goo). They also will eat your weed and projectile vomit it back up, which isn’t pleasant and a waste of perfectly good weed.
8. Dental Work
I thought it would be a good idea to smoke a little prior to some extensive dental work I had years back. Unfortunately, it just heightened the torturous sensations. Pretty soon, I thought the dentist had it out for me like Olivier in Marathon Man. My buzz was literally drilled out of my head.
9. Existential Angst
There is no god. You are all alone. The people are laughing at you and you look ridiculous. The world feels dry, chalky and desolate and you’re the only scrap of humanity left. The best you can do is listen to some Pink Floyd and embrace the painful truth. Cheetos may help but I make no guarantees.
10. Alien Abduction
I know, it depend on the alien, of course. Some aliens are totally down for a good time but others are into naval probing and mind melding. I find the smaller, ET-style aliens are much more easy going than the ones with the two rows of teeth.
So watch out for buzz kills. Life is short and highs aren’t cheap. Remember: you can always just walk away…even from the cops. Especially from the cops. Go do your own thing. Create your own world. Screw everyone else. Marshmallow pies await you, my friend.
Beth Mann is a popular blogger and writer for Open Salon and Salon. She is also an accomplished artist with over 15 years of experience, as well as the president of Hot Buttered Media. She currently resides at the Jersey shore where she can be found surfing or singing karaoke at a local dive bar.
Contact: maryjane {at } freedomisgreen.com
4/12/2011 – The nascent medical marijuana program in New Jersey may change the laboratory research landscape for cannabis. Several of the first six Alternative Treatment Centers are planning heavy investments (tens of millions of dollars) into lab equipment and manpower. Although explained away as regulatory compliance the long-term profits from this type of science could be substantial.
In other states the legal medical marijuana industry consists of small businesses using a holistic model of care. The Garden State is exploring a centralized system modeled on corporate health care instead. This could be the biggest change yet for the domestic medical cannabis market.
The result could be a disaster for patients like Sandy Faiola in Asbury Park, NJ and Charles Kwiatkowski in Hazlet who both live with Multiple Sclerosis. They joined well-known MS patient Montel Williams on a recent Dr. Oz Show. All three use raw Cannabis flowers to treat their symptoms and they all must access the underground market for relief.
New Jersey’s draft regulations – set to be finalized in May – call for each licensed facility to grow just three strains of cannabis, all of them less than 10 percent THC. Patients would only be allowed two ounces per month. The soviet-style regulated supply will be inadequate for Chuck and Sandy. They may continue to face arrest even though they have supporting physicians and would fully qualify for the program because they will need to find better quality pot on the street.
The dust never really settled in NJ for the medical marijuana debate, the battle lines only shifted. Governor Chris Christie, a conservative Republican with national presence, has been right in the middle since his first day in office. While bulldozing through a difficult budget, the characteristically aggressive Governor also rolled his heavy tracks over local AIDS and cancer patients. He successfully delayed the implementation of the compassionate use law for over a year, now Christie is pushing forward a set of regulations for therapeutic cannabis have their roots in deepest bedrock of big-money politics.
Half of the first six Alternative Treatment Centers were awarded to groups who have close ties right back to the Christie Administration. Democrats suddenly got a green thumb too; another licensed ATC has the Deputy Majority Leader in the State Assembly, Thomas Giblin, on the medical advisory board.
Then the two top officials at the Department of Health and Senior Services who have overseen the NJ medical marijuana program for over a year, Dr. Poonam Alaigh and Dr. Susan Walsh, resigned just after the ATC awards. It was a strange and still unexplained twist, but somehow par for the course in NJ.
Now, even the most politically connected marijuana production centers in the country are still complaining about Governor Christie’s very unscientific ‘ten-percent cap’ on THC potency. Because of federal prohibitions cannabis research in the United States is very limited. By exploiting the current conflict between state and federal law the ATCs in New Jersey could be used to study marijuana and its component cannabinoids for pharmaceutical endeavors years down the road. Limiting THC might interfere with the super-lab concept.
But Sandy, Chuck and Montel don’t need research or something years away. Thousands like them risk arrest every day as Governor Christie demonizes medical marijuana programs in other states while select politicos are awarded the pot futures. The Compassionate Use Medical Marijuana Act had a model to bring sick and terminal patients out of the underground marijuana market. It was not passed as a plan to turn marijuana into a processed pharmaceutical.
Thankfully the Legislature is ready to act. Senator Nicholas Scutari has introduced SCR151, a resolution that would invalidate the worst parts of Governor Christie’s proposed regulations. The rare legislative maneuver is meant to maintain the integrity of the compassionate use law and the state Constitution. If successful, the move could re-focus the regulations on the patients instead of business interests. The Senate and the Assembly have already passed similar resolutions and it would not require the Governor’s signature.
Still, the fact that health insurance companies, pharmaceutical manufactures, mainstream political players and hospital groups now actually own most of New Jersey’s regulated marijuana market is a major sea-change for the issue. The debate is no longer centered on whether medical cannabis should be legal or not but who makes the money.
Seriously ill and terminal residents use marijuana safely every day. Humans have used it for thousands of years and American medical cannabis is already turning a healthy profit. But the big green bubble of the US cannabis economy is inflated only by federal policy; the current cost for high-grade medical cannabis is simply the price of prohibition. The mainstream corporate interests looking to farm some of that cash have found fertile ground in the Garden State.
You know, the real problem here is the fact that this woman and her friends are incredibly boring – pot or not. Don’t go blaming the weed.
The captions become increasingly funny though. They include:
“Do marijuana smoking men make good husbands? Are they reliable? Responsible?”
“While many claim to function well on grass, outside observers disagree.”
“Marijuana can be a gateway to other drugs, such as mescaline.” [Really? Mescaline? Who can get their hands on that stuff?]
Beth Mann is a popular blogger and writer for Open Salon and Salon. She is also an accomplished actor and director with over 15 years of experience, as well as the president of Hot Buttered Media. She currently resides at the Jersey shore where she can often be seen surfing or singing karaoke at the local dive bar. Contact: maryjane {at } freedomisgreen.com
Other blogs:
The NCAA men’s basketball tournament was announced March 17th with a wave of free brackets, guides, Apps, and various experts that give the impression of mystical haruspices with their predictions.
This year we need a new way to determine final four picks. This is your chance to change the way you root for teams, here is a quick guide to base your picks on the quality of the universities contributions to the Cannabis and cannabinoid research field.
Here are final four picks for the 2013 NCAA tournament based on cannabinoid research:
Southern Division:
This year my pick for the southern division is the Virginia Commonwealth University (VCU). VCU has generated a lot in terms of cannabis and cannabinoid research. There are a lot of great researchers at VCU, rewarded with substantial grant funding for many different project. The late and great Billy Martin was a VCU professor who is accredited with “changing the landscape of drug abuse research in this country.”
Here a few projects that are being funded:
The Discovery and Characterization of New Endocannabinoids. Many people are starting to learn about anandamide and 2-AG the THC-like compounds made by our body, but there could dozens if not 100s of these endocannabinoids that our body can make for a variety of purposes.
Cannabis-like compounds to treat HIV/AIDS associated Brain Inflammation. Cannabinoid receptor activation may be able to prevent brain damage associated HIV/AIDS disease progression
Increasing Cannabinoid Receptor Activity to Fight Alzheimer’s Diseases. This study uses an approach to increase anandamide levels by inhibiting the protein FAAH. Increasing endocannabinoid system activity has beneficial effects on cognitive decline in animal models of the disease.
In 2012, VCU researchers published their cannabinoid research in prestigious science such as the British Journal of Pharmacology and Journal of Molecular Pharmacology.
Eastern Division
Temple University continually produces high quality cannabinoid and drug abuse research. Temple researchers have published a study showing that cannabinoids can decrease HIV replication and a research team has received a grant to study the protective effects of CB2 receptor activation in the brain. Temple University is also home to some of the leading Ph.D experts in cannabinoid research, such as Jahan Marcu (Cannabis Researcher of the year 2012).
Western Division
For decades Ole Miss has been growing Cannabis for researchers and patients. Thanks to the tireless work of Mahmoud Elsohly a few lucky researchers have received NIDA “marijuana cigarettes.”
These studies demonstrated that smoked Cannabis is effective for treating chemotherapy induced nausea and vomiting, as well as providing effective relief from neuropathic pain.
The surviving patients under the IND program receive about 300 “marijuana cigarettes” a month, 10 joints a day is the approximate recommendation to treat symptoms of their incurable diseases (On a personal note, Dr. Elsohly is also one of the nicest and most open researchers I have ever met).
Midwest Division
Michigan State University has many active cannabinoid researchers who have published on a range of topics:
Role of CB1 receptors in the immune system
John McPartland, a cannabis and endocannabinoid expert also publishes some of his work via Michigan State University. Researchers at Michigan State have also received a grant to study the potential of cannabinoids to stimulate new brain cell formation.
Summary
The final four of NCAA division I tournament of cannabinoid research would consist of Temple, VCU, Ole Miss, and Michigan State University. It’s a tough call, but Temple has the potential to take cannabinoid and drug abuse research to another level (However, I received my Ph.D from Temple and that may be a conflict of interest for this final four pick).
Temple University aside, Ole Miss would go all the way if the tournament was based simply on Cannabis research.
Ole Miss is the only place where you can find marijuana growing that is completely “legal”, as in the Feds and the DEA recognize its legitimacy; it is also the ONLY source of Cannabis for research purposes.
The ball is literally in Ole Miss’ court. However, VCU remains a cut above the rest, a deep team with a rich history of accomplishment and notoriety in the cannabinoid research field.
Jahan Marcu, Ph.D, is currently investigating the pharmacology of cannabinoid receptors. He was working at the California Pacific Medical Center Research Institute when exciting discoveries were made showing enhanced anti-cancer effects with THC and CBD from the Cannabis plant. The findings were published in the Journal of Molecular Cancer Therapeutics. In 2009 he received the Billy Martin Award from the International Cannabinoid Research Society (ICRS) and in 2013 was named Cannabis Researcher of the Year. Jahan is currently the vice-chair the Medical and Scientific Advisory Board at Americans for Safe Access (ASA). Questions? Contact [email protected]
DISCLAIMER: The views and opinions expressed are those of the author and do not necessarily represent any University, business or affiliates. While the information provided in this blog is from published scientific studies it is not intended to diagnose or treat any disease.
7/28/2011 – Time magazine made a flawed, sensationalistic attempt at covering cannibinoid research in a recent article. The piece details the effects of a synthetic cannabinoid (called JWH-133) and its ability to deter cocaine addiction in an animal model by activating the CB2 receptor in the brain. The implications of this study imply that cannabinoids could be potentially used as an “exit” drug for cocaine users. But Time confused the synthetic drug used in the study with a natural substance called cannabidiol or CBD.
Unfortunately, the seemingly good news about CB2 receptors and the treatment of cocaine addiction was over-shadowed by a plethora of inaccurate scientific information.
Here are the three main points that Time forgot:
One of the most basic concepts in cannabinoid science is that THC activates CB1 and CB2 receptors, but CBD does not activate CB1 and CB2 receptors. To refute this fundamental understanding of cannabinoid receptors is an insult to the scientific community and ultimately does more harm than good. As a scientist, this type of research is extremely complex and all news organizations will need to do a better job when conveying information to the public.
Dr. Raphael Mechoulam – The scientist that Time forgot
Jahan Marcu is currently investigating the pharmacology of cannabinoid receptors. He was working at the California Pacific Medical Center Research Institute when exciting discoveries were made showing enhanced anti-cancer effects with THC and CBD from the Cannabis plant. The findings were published in the Journal of Molecular Cancer Therapeutics. In 2009 he received the Billy Martin Award from the International Cannabinoid Research Society (ICRS). Jahan is currently the vice-chair the Medical and Scientific Advisory Board at Americans for Safe Access (ASA). Questions? Contact [email protected]
DISCLAIMER: The views and opinions expressed are those of the author and do not necessarily represent any University, business or affiliates. While the information provided in this blog is from published scientific studies it is not intended to diagnose or treat any disease.
illustration from Skunk Magazine
Printed in the current issue of Skunk Magazine; by Chris Goldstein and Beth Mann from freedomisgreen.com – It is 2012 and a team of political super-villains is plotting to keep marijuana illegal in the USA forever. The steady march to make holistic marijuana therapy available in the US is on the brink of being taken over and exploited indefinitely.
This subversive and nefarious attack is most apparent in states like California. The federal storm troopers smashing up dispensaries and beady-eyed IRS guys seizing property are simply the henchmen.
The new strategists include corporate interests and Big Pharma. These sharks smelled the cash in the water and have quickly allied themselves with old school prohibitionists for a full scale market takeover.
This evil scheme isn’t just happening in the West where legal, upstanding dispensaries are closed by the dozens; it’s a national coup with a powerful command post on the East Coast.
The State of Christie
New Jersey is a celebrity state for which most have a certain familiarity. Watching a Kevin Smith flick, singing along with The Boss and following Snooki on Twitter makes anyone feel like they have an intimate knowledge of the Garden State.
Sandwiched between New York City, Philadelphia and Washington, DC, there is a kind of unique, center-of-the-storm mentality to true New Jerseans. Citizens are diverse and generally wear their residency with a certain weary pride.
Yet New Jersey is the septic tank of American politics – housing some of the most off-balance, drama-filled, high-dollar and just plain sleazy elected officials in the country. Leading the pack is our Tony Soprano-like governor: Chris Christie.
Large, loud and generally angry, Christie’s most distinguishable feature is his comic-book proportions. He isn’t slightly rotund–he’s extremely obese. Yet he is light on his feet and quick with a smile. Christie possesses that superpower charm that politicians must hone in order to succeed. In fact, his girth is disarming; it distracts you from the real monster underneath.
Chris Christie has always been a political animal. A stint as a county freeholder paved his way to the State Assembly but local Republicans smacked him down at the polls. Without an elected seat, Christie haunted Trenton as a professional lobbyist. In 2000 he found his niche raising campaign cash for George W. Bush and getting chummy with Karl Rove. In 2001, Christie was tapped by President GW Bush to be the US Attorney for New Jersey.
Each state has federal prosecutors assigned and appointed by the President. The job of the US Attorneys is to fight the most serious crimes on behalf of Uncle Sam: mobsters, gangsters and Ponzi scheme operators.
This job also taught Christie all the inside baseball he would need to leverage federal prosecutors over medical marijuana later in his career.
The Gray Area Grows
US Attorney General Eric Holder, the boss of all the US Attorneys,issued a cryptic communique in 2009 concerning medical marijuana. Drafted by Deputy Attorney General David Odgen, it is now commonly referred to as the “Ogden memo.”
Forced to define a position on medical cannabis for the Obama administration, Ogden created an important outline: federal resources were not be used to prosecute individual American citizens using marijuana for a serious illness.
But Ogden had to admit, in the same memo (and in formal legalese), that US Attorneys should uphold federal law and shutdown cannabis facilities even if they were fully regulated by state law. The contradiction has created a complete circus ever since.
These wide-open loopholes left the US Attorneys, US states, and even the cannabis industry to their own interpretations. Dispensary owners viewed this protection to the individual patients as applying to their businesses. They were in for a rude awakening.
The Golden State of CA is currently experiencing its most serious sweep of dispensary shutdowns under the direction of US Attorney Melinda Haag. Like Christie, Haag’s appearance speaks volumes, and exudes a certain “cackling evil witch” quality. She aligned all of her federal resources – The Drug Enforcement Administration (DEA), The Internal Revenue Service (IRS) and even The Department of Homeland Security (DHS) – to rabidly go after individual dispensary businesses.
While other US Attorneys in Michigan, Oregon and Colorado have taken some similar action, Haag has stood alone in her dogged and maniacal pursuit of federal marijuana prohibition. That gray area of conflict between state and federal law gives Haag full discretion to act how she pleases.
The No Garden State
On January 18, 2010, one day before he left office after one term,former New Jersey governor Jon Corzine signed the Compassionate Use Medical Marijuana Act (CUMA) of New Jersey into law. Patients were promised full implementation within six months. Sponsoring legislators heralded it as the most “restrictive” law of its type in the nation, much to the chagrin of local activists.
New Jersey’s law was the first to eliminate home cultivation by registered patients. Instead, all qualifying residents would be forced into an approved Alternative Treatment Center (ATC) for their legal pot.
And while strict in measure, the law still lacked needed regulations and a formal structure. That was left to the incoming administration and has proven to be an unfortunate opportunity for conservative prohibition enthusiasts. On January 19, 2010, Chris Christie was sworn in as Governor,on the heels of serving as US Attorney.
Pill Pushers See Green
The old saying that politics makes strange bedfellows was probably invented outside of a cheap motel on the NJ Turnpike.
Bristol-Myers Squibb, Pfizer, Johnson & Johnson and Merck all have major research laboratories in New Jersey. Some of their major corporate offices are based here –and not because they like Bon Jovi.
These pharmaceutical mega-giants have spent decades and billions of dollars lobbying in Trenton. This has paid off in the form of tax-breaks, favorable zoning and contracts with state academic institutions, like universities. And they aren’t the only ones: insurance companies and major hospital groups have also worked hard to make the Garden State a very comfy base for their global businesses of chemical-based healthcare.
While these mainstream medical groups have kept marijuana at arm’s length elsewhere, they have a different angle in New Jersey. The component cannabinoids within the natural cannabis plant have long been the Fort Knox of the pharma industry. This potential money-making drug is kept under lock and key by the Feds. But in New Jersey, they are drilling into the vast and wealthy vault of pharmaceutical derivatives.
Governor Chris Christie’s first move on medical marijuana showed why he is so dangerous. In 2010 he bought time for his corporate plan to solidify and then corralled the support of the NJ Legislature. The same politicians who had fought for years to get the compassionate law passed instantly acquiesced to Christie.
They smelled the cash too.
Christie and his administration have been able to create the cannabis program at their own pace and to their own design. What has emerged, almost three years late, is a Soviet-style system that is the biggest threat to the small business, holistic medical marijuana industry in America today.
Welcome to the ominous beginnings of Corporate Cannabis controlled by Big Business.
The super villain master plan is about to bring this show on the road, coming to a town near you.
Hammer and Sickle Time
Chris Christie’s designs for medical marijuana seem like they were crafted over a dinner with Josef Stalin. A set of 128-page regulations was dropped like a ton of bricks in 2010. The Department of Health, the Department of Consumer Affairs, The Office of the State Attorney General and even the Governor’s Counsel [even the State Police] would have their hands on every step of the process.
This is government at its biggest and most intrusive; the polar opposite of the conservative “hands off” Republican ideals that Christie claims to harbor.
To advocates and patients, the rules for the ATCs were nothing short of draconian. They limit growing to only three strains of cannabis per ATC and none can exceed 10% THC potency.
Patients are also limited to just 2 ounces of this mid grade pot per month. It cannot be delivered to a patient’s home; the seriously ill resident or a single designated caregiver must visit the ATC to purchase their medicine. The only three forms of cannabis allowed to be sold by a New Jersey ATC are raw plant material, lozenges and a topical cream.
No hash, no edibles, no tinctures, no genetic variety. Sterile and homogenized; NJ’s castrated cannabis has become barely medicine and barely accessible.
But it didn’t stop there. The politicians who sponsored the law said that they didn’t want a “California or Colorado” type of program, implying that anyone with a common cold could have easy access. So NJ physicians are now forced to join a special registry in order to recommend medical marijuana. Seriously ill residents cannot even apply for their ID card unless they go through one of the handful of approved doctors.
The Garden State Pot Doctor List opened in late 2011 and only about 150 of the 30,000 physicians in New Jersey signed up. When the patient registry was opened in August 2012, this concept proved itself a dismal failure. Only 18 qualifying patients registered after a week, proving if you close enough doors, few will enter.
The Soprano System
While NJ regulators starved the patients in need, they happily tossed juicy bones to corporate interests involved with mainstream medicine. Only six Alternative Treatment Centers will be providing all of the legal cannabis for a state of nine million people. This was the birth of an exclusive, state-run cartel.
Making sure to keep it in the family, Christie’s DOH awarded the NJ Alternative Treatment Center’s contracts to business groups with deep connections to Big Pharma and machine politics.
Freedomisgreen.com filed an Open Public Records Act request to obtain the ATC applications. Analysis revealed that the winners plan to invest as much as $70 million to start up each site. Much of the capital will be spent on laboratory equipment and scientists’salaries to conduct private research on cannabinoids.
The brother of former Republican NJ Governor Christine Todd Whitman, Mr. Webster Todd Jr., is the CEO of Compassionate Sciences Inc. Todd used to be the Chairman of the National Transportation Safety Board, a far cry from being an experienced cannabis provider.
But the buddy system doesn’t stop there. As of this writing,only one out of the six NJ ATC facilities has a full permit to grow marijuana: Greenleaf Compassion Center. NJ Assemblyman Thomas Giblin, a Democrat, is on their Medical Advisory Board. Giblin is the only sitting state elected official in the nation to be involved in this capacity at a medical marijuana facility.
*Note – As of 11/16/2012 Greenelaf has still refused to begin selling cannabis to patients citing tax concerns – even though they are the only facility fully permitted to do so.
Playing Chicken with the Fed
Chris Christie figured out how to concentrate the cash but the Stalin-style regulations weren’t enough; he had another card to play.
With his knowledge as a US Attorney, he manufactured a new conflict between New Jersey’s CUMA and federal law.
Christie claimed that he feared that NJ state employees could be at risk of federal prosecution. Using all of his expertise and power, Christie was making the ultimate move into the gray area of medical cannabis laws.
The Governor directed NJ Attorney General Paula Dow to send a letter to US Department of Justice. Christie was making President Obama and the US DOJ clarify their position on state authorized medical marijuana facilities so he could capitalize on the response.
This was all pure politics. Republican conservatives cheered. The Obama administration squirmed. The medical marijuana industry in America, rightfully, held its breath.
Deputy US Attorney General James Cole issued a new memo on June 2011 in response to New Jersey but directed to all US Attorneys. Freedomisgreen.com was the first to obtain the document and distributed its full text to the public.
Here’s the critical section:
The Odgen Memorandum was never intended to shield such activities from federal enforcement action and prosecution, even where those activities purport to comply with state law. Persons who are in the business of cultivating, selling, or distributing marijuana, and those who knowingly facilitate such activities, are in violation of the Controlled Substances Act, regardless of state law. Consistent with the resource constraints and the discretion you may exercise in your district,such persons are subject to federal enforcement action, including potential prosecution.
State employees ran no risk of federal arrest. Still the USDOJ was obviously speaking directly the medical marijuana community. In layman’s terms: Ogden said that spending tax dollars to have federal prosecutors and DEA soldiers attack an American in a wheelchair smoking a joint (or growing in a closet) was a waste. But the DOJ firmly upheld the shutting down of any shop that provided that cannabis.
The Cole memo provided steel-enforcement for zealots like Melinda Haag. That was Chris Christie’s plan: provide anti marijuana US Attorneys extra ammo to go after legitimate, small-business dispensaries and make room to install their own corporatized cartel scheme.
The End Game
We used to worry that Reefer Madness-style opposition would roll back state medical marijuana laws. But the new take-over strategy relies on them being in place. Replicating the New Jersey law and the subsequent regulations is the new opposition key. Delaware and Connecticut are the most recent states to pass compassionate use: nearly exact copies of NJ. With all the built-in giveaways to corporate medical interests, this blueprint is an easy sell [to slick politicians].
Political pressure is also being put on state legislatures and even down to the county level to amend or re-regulate existing medical cannabis laws. (Guess which model they’re pushing?)
The current medical marijuana industry in America could be on the edge of a real doomsday. The next move from the likes of Haag and Christie is to shut down every single small-business cannabis garden or dispensary operation and replace them with corporate cartels. Imagine just six medical cannabis facilities for all of California.
To maximize the long-term profits, the big corporations will likely use their significant lobbying clout to fight national marijuana legalization. Given enough time to conduct secret research under exclusive state contracts, they will likely develop synthetic copies of natural cannabinoids in pill form. Those drugs would be perfectly legal and patent-able, just like Marinol (the 100% synthetic THC).
Hope still lingers. State-level pro-marijuana politicians like Assemblyman Tom Ammiano in CA and Diane Russell in Maine are pushing hard for freedom from these constraints. Longtime supporters in Washington DC like Reps. Barney Frank (D-MA) and Ron Paul (R-TX) are retiring but a savvier generation is getting elected. Congressman Jared Polis (D) of Colorado is a good example.
Awareness of the opposition plan gives us tools to fight it.
The immediate pressure coming down on California from US federal agencies can be alleviated immediately by Congress or the President.
But now, only a President and/or federal legalization of cannabis will stop the corporate medical marijuana cartels run by the states.
Their next move is to go international with this wretched scheme.
Unless we focus our efforts like a laser-beam on President Obama’s stance, the prohibitionist villains will prevail.
Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions? [email protected] Note – This article was originally published on October 1, 2012 in Skunk Magazine, in print only.
Medical marijuana growing in CA
6/2/2011 – The most common plant varieties of Cannabis in North America are THC-rich strains. These have have dominated the underground market for 100 years because THC is the main cause of the euphoric effect or ‘high.’ But the Cannabis plant is more than just tetrahydrocannabinol (THC); it is a treasure trove of potentially therapeutic compounds (Mechoulam 2005).
‘THC tunnel vision’ in America has prevented the identification and capitalization of the other, extremely valuable cannabinoids. Scientists are now taking on more research to look closer at the mechanics of these no-high cannabinoids.
The Cannabis plant can produce a rich mixture of active ingredients, these unique compounds are called cannabinoids. Everyone knows THC, but it is important to be aware of some other 3-letter compounds that are showing great promise for medical applications. These include: cannabidiol (CBD), cannabigerol (CBG), cannabichromene (CBC) and tetrahydrocannabivarin (THCV), to name only a few. Many of these compounds have been shown in laboratory studies to produce greater therapeutic effects than THC, without unwanted side effects (Russo-Guy 2006).
CBD varieties possess many ancient and unique genetics required to produce medically relevant cannabinoids. Plants containing a high amount of CBD have also become the second most popular choice in the supply of medical cannabis. A recent surge in demand for CBD-rich medical cannabis has also spurred an even greater interest in the identification and exploration of other cannabinoid varieties.
CBG has been shown to have pain-relieving and anti-depressant effects that are greater than THC (Evans 1991, Musty-Deyo 2006). CBG does not interact with CB1 and CB2 receptors like THC but instead interacts with different receptors, some that multi-billion dollar drugs target. These include adrenoreceptors and serotonin (5-HT1A) receptors (Cascio 2010).
Even though CBG was first isolated in 1964, the first report of a high CBG-producing plant wasn’t until the 1980’s, when it was discovered in a French hemp population. In 2005, a team of researchers identified a CBG plant in Italy.
They crossed this CBG plant with other THC and CBD plants of “good breeding value.” With the help of genetic analysis and chromatography, they were crossbred with different varieties and cultivars, until they identified a strain that produced high amounts of CBG, with little to no THC (de Meijer et al.2005).
Today, the only known high-yielding CBG variety is presently in the greenhouses of GW Pharmaceuticals, where CBG makes up a small but consistent portion of Sativex, a cannabinoid mouth spray. So while CBG and other varieties exist, they’re current exploration and usage seem to be sparse or under lock and key.
In America, there is a proliferation of cultivars (clones) of THC varieties given many different names (e.g., Skunk, Silver Haze, White Widow). Patients are given the illusion of variety where there may be none.
Fortunately, CBG, THCV and other unique strains may organically surface, either directly from the natural proliferation of CBD varieties or due to the plant’s “hypermorphic genetics” which can jump around spontaneously – Cannabis is a weed after all.
Potency testing may be able to identify cannabinoid compounds post-harvest, but only genetics and careful selection will allow the medical cannabis industry to track heritability. This will greatly enhance the generation of new and therapeutically useful strains of Cannabis, just like those that have been created over the last 20 years in Europe.
Jahan Marcu is currently investigating the pharmacology of cannabinoid receptors. He was working at the California Pacific Medical Center Research Institute when exciting discoveries were made showing enhanced anti-cancer effects with THC and CBD from the Cannabis plant. The findings were published in the Journal of Molecular Cancer Therapeutics. In 2009 he received the Billy Martin Award from the International Cannabinoid Research Society (ICRS). Jahan is currently the vice-chair the Medical and Scientific Advisory Board at Americans for Safe Access (ASA). Questions? Contact [email protected]
DISCLAIMER: The views and opinions expressed are those of the author and do not necessarily represent any University, business or affiliates. While the information provided in this blog is from published scientific studies it is not intended to diagnose or treat any disease.
dronabinol delta 9 – THC
6/21/2011 by Jahan Marcu – Since 2001, Dr. Kirsten Muller-Vahl and colleagues have published research articles demonstrating the safety of Delta9-THC in patients with Tourette’s Syndrome. This is a disease characterized by involuntary movement and vocalizations (a.k.a. tics). In 2003, the authors showed that, “Delta9-THC causes neither acute nor long-term cognitive deficits” in patients suffering from Tourette’s.
Recently this group of clinical researchers published a Letter to the Editor of Psychiatry Research outlining their findings in a Tourette’s patient given 15mg of delta9-THC per day. The authors measured the patient’s driving ability with a computerized test and compared it to the patients performance with and without delta9-THC. The author’s state, “In comparison with the drug-free phase (of the treatment), there was a clear improvement in concentration and visual perception during THC therapy.”
The patient, a 42 year old truck driver referred to as Mr.H, first displayed symptoms of this disease at age 6. When he appeared at the clinic for this study he was suffering from multiple tics of the head, arm and leg: Not good symptoms to have for a truck driver. Furthermore, Mr.H’s medical history showed that all available drug treatments were ineffective including dopamine blocking agents, alpha-2 drugs, clonazepam, and terabenazine. Within 2 weeks of delta9-THC treatment Mr.H’s symptoms were reduced by 75%.
The authors call for more research on driving ability in patient’s with Tourette’s while they are under the effect of delta9-THC . The authors do not discuss the possibilities of Cannabis or delta9-THC on the driving ability of patients with other neurological diseases, such as multiple sclerosis.
It is safe to assume that if you can stop chronic muscle spasms and involuntary jerking motions in a patient then you have made them a better driver. This new patient data comes after the DMV in California changed its policy on Medical Cannabis patients when it was successfully sued by American’s for Safe Access. CA DMV refused to renew the license of a medical cannabis patient, despite a “sparkling clean driving record.”
The implications for these findings adds to the on going argument regarding THC levels in the blood and driving ability. While there is still a great debate on the effects of Cannabis and driving in healthy subjects, it appears that persons suffering neurological disorders may have an improved ability to drive.
Despite the remarkable effects delta9-THC can have on the driving ability in a patient with Tourette’s, don’t expect law enforcement or the DMV to treat medical cannabis patients any differently from recreational users.
Jahan Marcu is currently investigating the pharmacology of cannabinoid receptors. He was working at the California Pacific Medical Center Research Institute when exciting discoveries were made showing enhanced anti-cancer effects with THC and CBD from the Cannabis plant. The findings were published in the Journal of Molecular Cancer Therapeutics. In 2009 he received the Billy Martin Award from the International Cannabinoid Research Society (ICRS). Jahan is currently the vice-chair the Medical and Scientific Advisory Board at Americans for Safe Access (ASA). Questions? Contact [email protected]
DISCLAIMER: The views and opinions expressed are those of the author and do not necessarily represent any University, business or affiliates. While the information provided in this blog is from published scientific studies it is not intended to diagnose or treat any disease.